GraphTx is developing a next-generation lab-in-the-loop AI platform to transform drug discovery in inflammation and immunology
GraphTx is developing a next-generation lab-in-the-loop AI platform to transform drug discovery in inflammation and immunology. The company combines sophisticated live patient cell approaches with advanced machine learning to overcome the unique challenges of developing therapies for complex inflammatory diseases.